<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00389597</url>
  </required_header>
  <id_info>
    <org_study_id>LDR-001</org_study_id>
    <nct_id>NCT00389597</nct_id>
  </id_info>
  <brief_title>LDR Spine USA Mobi-C(R) Cervical Disc Prosthesis IDE</brief_title>
  <official_title>LDR Spine USA Mobi-C(R) Cervical Disc Prosthesis IDE</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>LDR Spine USA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>LDR Spine USA</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this investigation is to establish the safety and effectiveness of the LDR
      Spine Mobi-C® Cervical Disc Prosthesis which is an anterior cervical interbody mechanical
      device. The primary objective of the study is to evaluate the overall success rate of the
      investigational device as compared to the control in the treatment of patients with
      symptomatic DDD with radiculopathy or myeloradiculopathy at one or two adjacent levels.
      Patients should be without prior cervical fusion between C3 and C7 and unresponsive to
      non-operative conservative treatment for six weeks after symptom onset or have the presence
      of progressive symptoms or signs of nerve/spinal cord compression despite continued
      non-operative conservative treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Objectives of the Investigation

      The purpose of this investigation is to establish the safety and effectiveness of the LDR
      Spine Mobi-C® Cervical Disc Prosthesis which is an anterior cervical interbody mechanical
      device. The primary objective of the study is to evaluate the overall success rate of the
      investigational device as compared to the control in the treatment of patients with
      symptomatic DDD with radiculopathy or myeloradiculopathy at one or two adjacent levels.
      Patients should be without prior cervical fusion between C3 and C7 and unresponsive to
      non-operative conservative treatment for six weeks after symptom onset or have the presence
      of progressive symptoms or signs of nerve/spinal cord compression despite continued
      non-operative conservative treatment.

      Study Design Rationale

      The study is a prospective, randomized, multi-center, concurrently controlled investigation,
      in which the study device will be compared to the control treatment consisting of
      conventional anterior cervical discectomy and fusion (ACDF) in accordance with the
      Smith-Robinson procedure. Patients will be followed for two years postsurgery (primary
      endpoint) and at 3, 4, 5, and 7 years thereafter.

      Duration of the Investigation

      Patients will be followed post-operatively at 6 weeks, and 3-, 6-, 12-, 18-, and 24-months.
      After 24 months, patients will continue to be followed at 3,4, 5 and 7 years.

      Design Techniques to Avoid Bias

      To eliminate selection bias, investigational and control comparison groups will be assigned
      at random.

      Institutional Review Board

      No clinical studies will begin without documented approval of the clinical investigation by
      the Institutional Review Board (IRB) affiliated with the study center.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2006</start_date>
  <completion_date type="Actual">November 2015</completion_date>
  <primary_completion_date type="Actual">March 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite Definition of Study Success</measure>
    <time_frame>2 Years</time_frame>
    <description>An individual subject in either treatment group was considered a success if the following criteria were met at 24 months:
Improvement in Neck Disability Index of at least 15/50 points in subjects with baseline Neck Disability Index scores of &gt;= 30/50 points, or a 50% improvement in subjects with a baseline Neck Disability Score score of &lt;30/50 where the Neck Disability Index is a measure designed to enable the physician to understand how much a subject's neck pain has affected his ability to manage everyday activities.
No study failures due to secondary surgical interventions at the index level
Absence of major complications defined as radiographic failure, neurologic failure, or failure by adverse event as adjudicated by the CEC</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">599</enrollment>
  <condition>Degenerative Disc Disease</condition>
  <arm_group>
    <arm_group_label>1 Level</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cervical artificial disc (investigational device) at 1 level compared with control procedure (ACDF) at one level</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2 Level</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cervical artificial disc (investigational device) at 2 levels compared with control procedure (ACDF) at two levels</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cervical Artificial Disc</intervention_name>
    <description>Cervical artificial disc mechanical device</description>
    <arm_group_label>1 Level</arm_group_label>
    <arm_group_label>2 Level</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 18-69 years.

          2. Diagnosis of radiculopathy or myeloradiculopathy of the cervical spine, with pain,
             paresthesias or paralysis in a specific nerve root distribution C3 through C7,
             including at least one of the following:

               -  Neck and/or arm pain (at least 30mm on the 100mm VAS scale).

               -  Decreased muscle strength of at least one level on the clinical evaluation 0 to 5
                  scale.

               -  Abnormal sensation including hyperesthesia or hypoesthesia; and/or

               -  Abnormal reflexes

          3. Symptomatic at one or two adjacent levels from C3 to C7;

          4. Radiographically determined pathology at one or two adjacent level(s) to be treated
             correlating to primary symptoms including at least one of the following:

               -  Decreased disc height on radiography, CT, or MRI in comparison to a normal
                  adjacent disc.

               -  Degenerative spondylosis on CT or MRI.

               -  Disc herniation on CT or MRI;

          5. Neck Disability Index Score of ≥15/50 or ≥30%;

          6. Unresponsive to non-operative, conservative treatment (rest, heat, electrotherapy,
             physical therapy, chiropractic care and/or analgesics) for:

               -  Approximately six weeks from radiculopathy or myeloradiculopathy symptom onset;
                  or

               -  Have the presence of progressive symptoms or signs of nerve root/spinal cord
                  compression despite continued non-operative conservative treatment.

        Note: Not a complete listing

        Exclusion Criteria:

          1. Reported to have an active systemic infection or infection at the operative site;

          2. Reported to have a history of or anticipated treatment for active systemic infection,
             including HIV or Hepatitis C;

          3. More than one immobile vertebral level between C1 to C7 from any cause including but
             not limited to congenital abnormalities and osteoarthritic &quot;spontaneous&quot; fusions;

          4. Previous trauma to the C3 to C7 levels resulting in significant bony or
             disco-ligamentous cervical spine injury;

          5. Reported to have had any prior spine surgery at the operative level;

          6. Reported to have had prior cervical fusion procedure at any level;

          7. Axial neck pain in the absence of other symptoms of radiculopathy or
             myeloradiculopathy justifying the need for surgical intervention;

          8. Disc height less than 3mm as measured from the center of the disc in a neutral
             position and disc height less than 20% of the anterior-posterior width of the inferior
             vertebral body;

          9. Radiographic confirmation of severe facet joint disease or degeneration;

        Note: Not a complete listing
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>69 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ralph Rashbaum, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Texas Back Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Texas Back Institute-West</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85015</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southern California Institute of Neurological Surgery</name>
      <address>
        <city>Escondido</city>
        <state>California</state>
        <zip>92122</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Massoudi &amp; Jackson Neurosurgical Association</name>
      <address>
        <city>Laguna Hills</city>
        <state>California</state>
        <zip>92653</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Memorial Orthopaedic Surgical Group</name>
      <address>
        <city>Long Beach</city>
        <state>California</state>
        <zip>90806</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eisenhower Medical Center</name>
      <address>
        <city>Rancho Mirage</city>
        <state>California</state>
        <zip>92270</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of California- Davis Medical Center</name>
      <address>
        <city>Sacramento</city>
        <state>California</state>
        <zip>95817</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spine Institute at St. John's Health Center</name>
      <address>
        <city>Santa Monica</city>
        <state>California</state>
        <zip>90404</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stanford University</name>
      <address>
        <city>Stanford</city>
        <state>California</state>
        <zip>94305</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Panorama Orthopedics and Spine Care</name>
      <address>
        <city>Golden</city>
        <state>Colorado</state>
        <zip>80401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southeastern Clinical Research</name>
      <address>
        <city>Orlando</city>
        <state>Florida</state>
        <zip>32804</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Orthopaedics North East</name>
      <address>
        <city>Fort Wayne</city>
        <state>Indiana</state>
        <zip>46825</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Spine Institute of Louisiana</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>71101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>GBMC Healthcare</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Neurologic Systems</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Mary's of Saginaw Field Neurosciences Institute</name>
      <address>
        <city>Saginaw</city>
        <state>Michigan</state>
        <zip>48604</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Simmons Orthopaedics and Spine Associates</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Orthopedic Spine Care of Long Island</name>
      <address>
        <city>Melville</city>
        <state>New York</state>
        <zip>11747</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oklahoma Spine &amp; Brain Institute</name>
      <address>
        <city>Tulsa</city>
        <state>Oklahoma</state>
        <zip>74132</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Austin Brain and Spine</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Foundation Surgical Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>West Texas Spine</name>
      <address>
        <city>Odessa</city>
        <state>Texas</state>
        <zip>79761</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Back Institute</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75093</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Texas Spine and Joint Hospital</name>
      <address>
        <city>Tyler</city>
        <state>Texas</state>
        <zip>75701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.accessdata.fda.gov/cdrh_docs/pdf11/P110009A.pdf</url>
    <description>FDA Approval 2 Level</description>
  </link>
  <link>
    <url>https://www.accessdata.fda.gov/cdrh_docs/pdf11/P110002A.pdf</url>
    <description>FDA Approval 1 Level</description>
  </link>
  <results_reference>
    <citation>Hisey MS, Bae HW, Davis R, Gaede S, Hoffman G, Kim K, Nunley PD, Peterson D, Rashbaum R, Stokes J. Multi-center, prospective, randomized, controlled investigational device exemption clinical trial comparing Mobi-C Cervical Artificial Disc to anterior discectomy and fusion in the treatment of symptomatic degenerative disc disease in the cervical spine. Int J Spine Surg. 2014 Dec 1;8. doi: 10.14444/1007. eCollection 2014.</citation>
    <PMID>25694918</PMID>
  </results_reference>
  <results_reference>
    <citation>Davis RJ, Kim KD, Hisey MS, Hoffman GA, Bae HW, Gaede SE, Rashbaum RF, Nunley PD, Peterson DL, Stokes JK. Cervical total disc replacement with the Mobi-C cervical artificial disc compared with anterior discectomy and fusion for treatment of 2-level symptomatic degenerative disc disease: a prospective, randomized, controlled multicenter clinical trial: clinical article. J Neurosurg Spine. 2013 Nov;19(5):532-45. doi: 10.3171/2013.6.SPINE12527. Epub 2013 Sep 6.</citation>
    <PMID>24010901</PMID>
  </results_reference>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 18, 2006</study_first_submitted>
  <study_first_submitted_qc>October 18, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 19, 2006</study_first_posted>
  <results_first_submitted>January 3, 2014</results_first_submitted>
  <results_first_submitted_qc>April 1, 2014</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 1, 2014</results_first_posted>
  <last_update_submitted>November 7, 2017</last_update_submitted>
  <last_update_submitted_qc>November 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 11, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>degenerative disc disease</keyword>
  <keyword>cervical arthroplasty</keyword>
  <keyword>Mobi C</keyword>
  <keyword>multilevel</keyword>
  <keyword>anterior cervical discectomy and fusion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intervertebral Disc Degeneration</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Meloxicam</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>One Level TDR Arm: 169 subjects randomized (5 not operated) One Level ACDF Arm: 87 subjects randomized (6 not operated) Two level TDR arm: 232 subjects randomized (7 not operated). Two Level ACDF Arm: 115 subjects randomized (10 not operated)</recruitment_details>
      <pre_assignment_details>1 level TDR enrolled 184 incl15 training cases (2 withdrew consent, 1 AE, 2 other). 1 level ACDF enrolled 87 with no training cases (4 withdrew consent, 2 other) for 245 randomized subjects. 2 level TDR enrolled 241 incl. 9 training cases (1 withdrew consent, 6 other); 2 Level ACDF enrolled 115 with no training cases (4 withdrew consent, 6 other)</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>1 Level TDR</title>
          <description>Cervical artificial disc (investigational device) at 1 level</description>
        </group>
        <group group_id="P2">
          <title>1 Level ACDF</title>
          <description>1 level control procedure (ACDF)</description>
        </group>
        <group group_id="P3">
          <title>2 Level TDR</title>
          <description>Cervical artificial disc (investigational device) at 2 levels</description>
        </group>
        <group group_id="P4">
          <title>2 Level ACDF</title>
          <description>2 level control procedure (ACDF)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="164"/>
                <participants group_id="P2" count="81"/>
                <participants group_id="P3" count="225"/>
                <participants group_id="P4" count="105"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>24 mo</title>
              <participants_list>
                <participants group_id="P1" count="156"/>
                <participants group_id="P2" count="75"/>
                <participants group_id="P3" count="221"/>
                <participants group_id="P4" count="99"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="156"/>
                <participants group_id="P2" count="75"/>
                <participants group_id="P3" count="221"/>
                <participants group_id="P4" count="99"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="6"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="6"/>
                <participants group_id="P3" count="4"/>
                <participants group_id="P4" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>1 Level TDR</title>
          <description>Cervical artificial disc (investigational device) at 1 level</description>
        </group>
        <group group_id="B2">
          <title>1 Level ACDF</title>
          <description>1 level control procedure (ACDF)</description>
        </group>
        <group group_id="B3">
          <title>2 Level TDR</title>
          <description>Cervical artificial disc (investigational device) at 2 levels</description>
        </group>
        <group group_id="B4">
          <title>2 Level ACDF</title>
          <description>2 level control procedure (ACDF)</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="164"/>
            <count group_id="B2" value="81"/>
            <count group_id="B3" value="225"/>
            <count group_id="B4" value="105"/>
            <count group_id="B5" value="575"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="161"/>
                    <measurement group_id="B2" value="80"/>
                    <measurement group_id="B3" value="222"/>
                    <measurement group_id="B4" value="101"/>
                    <measurement group_id="B5" value="564"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                    <measurement group_id="B4" value="4"/>
                    <measurement group_id="B5" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="86"/>
                    <measurement group_id="B2" value="45"/>
                    <measurement group_id="B3" value="112"/>
                    <measurement group_id="B4" value="45"/>
                    <measurement group_id="B5" value="288"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="78"/>
                    <measurement group_id="B2" value="36"/>
                    <measurement group_id="B3" value="113"/>
                    <measurement group_id="B4" value="60"/>
                    <measurement group_id="B5" value="287"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="164"/>
                    <measurement group_id="B2" value="81"/>
                    <measurement group_id="B3" value="225"/>
                    <measurement group_id="B4" value="105"/>
                    <measurement group_id="B5" value="575"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Composite Definition of Study Success</title>
        <description>An individual subject in either treatment group was considered a success if the following criteria were met at 24 months:
Improvement in Neck Disability Index of at least 15/50 points in subjects with baseline Neck Disability Index scores of &gt;= 30/50 points, or a 50% improvement in subjects with a baseline Neck Disability Score score of &lt;30/50 where the Neck Disability Index is a measure designed to enable the physician to understand how much a subject's neck pain has affected his ability to manage everyday activities.
No study failures due to secondary surgical interventions at the index level
Absence of major complications defined as radiographic failure, neurologic failure, or failure by adverse event as adjudicated by the CEC</description>
        <time_frame>2 Years</time_frame>
        <population>includes study failures, per protocol, that are carried forward for overall success</population>
        <group_list>
          <group group_id="O1">
            <title>1 Level ACDF</title>
            <description>control procedure (ACDF) at one level</description>
          </group>
          <group group_id="O2">
            <title>1 Level TDR</title>
            <description>Cervical artificial disc (investigational device) at 1 level</description>
          </group>
          <group group_id="O3">
            <title>2 Level ACDF</title>
            <description>Cervical artificial disc (investigational device) at 2 levels compared with control procedure (ACDF) at two levels</description>
          </group>
          <group group_id="O4">
            <title>2 Level TDR</title>
            <description>control procedure (ACDF) at two levels</description>
          </group>
        </group_list>
        <measure>
          <title>Composite Definition of Study Success</title>
          <description>An individual subject in either treatment group was considered a success if the following criteria were met at 24 months:
Improvement in Neck Disability Index of at least 15/50 points in subjects with baseline Neck Disability Index scores of &gt;= 30/50 points, or a 50% improvement in subjects with a baseline Neck Disability Score score of &lt;30/50 where the Neck Disability Index is a measure designed to enable the physician to understand how much a subject's neck pain has affected his ability to manage everyday activities.
No study failures due to secondary surgical interventions at the index level
Absence of major complications defined as radiographic failure, neurologic failure, or failure by adverse event as adjudicated by the CEC</description>
          <population>includes study failures, per protocol, that are carried forward for overall success</population>
          <units>percentage of subjects analyzed</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="75"/>
                <count group_id="O2" value="156"/>
                <count group_id="O3" value="99"/>
                <count group_id="O4" value="221"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="65.3"/>
                    <measurement group_id="O2" value="73.7"/>
                    <measurement group_id="O3" value="37.4"/>
                    <measurement group_id="O4" value="69.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>1 Level: Ho: pm-pc &lt;=-0.1 (inferiority) Alternative hypothesis: Ha: pm – pc &gt; -0.1 Where pm = the proportion of success in the Mobi-C group and the Pc = the proportion of success in the ACDF group.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The 95% one-sided confidence bound for testing non-inferiority using two proportion test with 10% non-inferiority margin.</non_inferiority_desc>
            <p_value>0.0021</p_value>
            <method>Farrington Manning</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <groups_desc>2 Level: Ho: pm-pc &lt;=-0.1 (inferiority) Alternative hypothesis: Ha: pm – pc &gt; -0.1 Where pm = the proportion of success in the Mobi-C group and the Pc = the proportion of success in the ACDF group.
2 Level: Ho: pm-pc &lt;= 0 (not superior) Alternative hypothesis: Ha: pm-pc &gt;0 Where pm = the proportion of success in the Mobi-C group and the Pc = the proportion of success in the ACDF group.</groups_desc>
            <non_inferiority_type>Non-Inferiority or Equivalence</non_inferiority_type>
            <non_inferiority_desc>The 95% one-sided confidence bound for testing non-inferiority using two proportioned test with a 10% non-inferiority margin.</non_inferiority_desc>
            <p_value>&lt;0.0001</p_value>
            <method>Farrington-Manning</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>24 months</time_frame>
      <desc>Adverse events are reported on all patients treated, including 24 surgical training subjects. Randomized total = 575, safety population total =599</desc>
      <group_list>
        <group group_id="E1">
          <title>1 Level TDR Arm</title>
          <description>Cervical artificial disc (investigational device) at 1 level</description>
        </group>
        <group group_id="E2">
          <title>1 Level ACDF Arm</title>
        </group>
        <group group_id="E3">
          <title>2 Level TDR Arm</title>
          <description>Cervical artificial disc (investigational device) at 2 levels</description>
        </group>
        <group group_id="E4">
          <title>2 Level ACDF Arm</title>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MedDRA (10.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="32" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="81"/>
                <counts group_id="E3" subjects_affected="56" subjects_at_risk="234"/>
                <counts group_id="E4" subjects_affected="34" subjects_at_risk="105"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiovascular</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="179"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="81"/>
                <counts group_id="E3" events="9" subjects_affected="7" subjects_at_risk="234"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="105"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gastrointestinal</sub_title>
                <counts group_id="E1" events="8" subjects_affected="5" subjects_at_risk="179"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="81"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="234"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="105"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Death</sub_title>
                <description>includes all deaths not related to the device - respiratory, cardiac, etc</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="81"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="234"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="105"/>
              </event>
              <event>
                <sub_title>Other</sub_title>
                <description>includes Blood/Lymphatic, Congenital/Genetic, Ear/Labyrinth, Endocrine, Eye, Immune, Metabolism/Nutrition, Musculoskeletal /CT, Benign Neoplasm, Nervous, Psychiatric, Repro, Skin, Vascular , Poisoning, Pregnancy, Social &amp; surgical/Medical procedures</description>
                <counts group_id="E1" events="8" subjects_affected="6" subjects_at_risk="179"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="81"/>
                <counts group_id="E3" events="14" subjects_affected="12" subjects_at_risk="234"/>
                <counts group_id="E4" events="13" subjects_affected="9" subjects_at_risk="105"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infection</sub_title>
                <description>Infection includes Superficial Wound – Cervical, Deep Wound – Cervical, Other Wound – Non Study Surgery, both Systemic and Local</description>
                <counts group_id="E1" events="5" subjects_affected="3" subjects_at_risk="179"/>
                <counts group_id="E2" events="6" subjects_affected="4" subjects_at_risk="81"/>
                <counts group_id="E3" events="9" subjects_affected="6" subjects_at_risk="234"/>
                <counts group_id="E4" events="4" subjects_affected="3" subjects_at_risk="105"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Heterotopic Ossification</sub_title>
                <description>Heterotopic Ossification includes Cervical – Index Level, Cervical – Adjacent Level and Non Cervical</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="179"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="81"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="234"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="105"/>
              </event>
              <event>
                <sub_title>Neck and/or Arm Pain</sub_title>
                <description>Neck and/or Arm Pain includes pain (and related pain terms) specific to neck (cervical spine) and arm pain (and related pain terms) specific to arm (spinal disorders are recorded elsewhere).</description>
                <counts group_id="E1" events="4" subjects_affected="3" subjects_at_risk="179"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="81"/>
                <counts group_id="E3" events="15" subjects_affected="10" subjects_at_risk="234"/>
                <counts group_id="E4" events="8" subjects_affected="6" subjects_at_risk="105"/>
              </event>
              <event>
                <sub_title>Non-union</sub_title>
                <description>Non-Union includes non-union, cervical fusion failure, pseudoarthrosis, and pending non-unions as reported ; limited to study surgery related events of non-union.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="81"/>
                <counts group_id="E3" events="3" subjects_affected="1" subjects_at_risk="234"/>
                <counts group_id="E4" events="14" subjects_affected="11" subjects_at_risk="105"/>
              </event>
              <event>
                <sub_title>Other pain</sub_title>
                <description>Other Pain including Shoulder, Back, Torso, Lower Extremity, Headache, Other</description>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="179"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="81"/>
                <counts group_id="E3" events="15" subjects_affected="10" subjects_at_risk="234"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="105"/>
              </event>
              <event>
                <sub_title>Spinal Disorder</sub_title>
                <description>Spinal Disorder including Cervical – Study Surgery, Cervical – Non Study Surgery and Non Cervical</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="179"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="81"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="234"/>
                <counts group_id="E4" events="8" subjects_affected="7" subjects_at_risk="105"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Cancer</sub_title>
                <description>All reported of AEs of cancer (malignancy or malignant tumor/neoplasm)</description>
                <counts group_id="E1" events="2" subjects_affected="1" subjects_at_risk="179"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="81"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="234"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="105"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Neurological</sub_title>
                <description>Neurological including Upper Extremity – Sensory, motor, reflex; Lower Extremity – Sensory, motor, reflex; Upper &amp; Lower Extremity – Sensory, motor, reflex; neck, back, spinal cord disturbance; gait disturbance, non specific and other</description>
                <counts group_id="E1" events="8" subjects_affected="5" subjects_at_risk="179"/>
                <counts group_id="E2" events="4" subjects_affected="3" subjects_at_risk="81"/>
                <counts group_id="E3" events="5" subjects_affected="5" subjects_at_risk="234"/>
                <counts group_id="E4" events="5" subjects_affected="5" subjects_at_risk="105"/>
              </event>
              <event>
                <sub_title>Upper Extremity Nerve Entrapment</sub_title>
                <description>including all reported AEs of Carpel Tunnel Syndrome and Cubital Tunnel Syndrome, including AEs directly attributed to Carpel Tunnel Syndrome or Cubital Tunnel Syndrome, as well as Carpal Tunnel surgery.</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="179"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="81"/>
                <counts group_id="E3" events="5" subjects_affected="4" subjects_at_risk="234"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="105"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Urogenital</sub_title>
                <counts group_id="E1" events="3" subjects_affected="2" subjects_at_risk="179"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="81"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="234"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="105"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Dysphagia/Dysphonia</sub_title>
                <description>includes all reported AEs of Dysphagia and other terms consistent with “difficulty swallowing” and all reported AEs of Dysphonia and other terms consistent with “voice change and/or disruption”.</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="81"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="234"/>
                <counts group_id="E4" events="2" subjects_affected="2" subjects_at_risk="105"/>
              </event>
              <event>
                <sub_title>Respiratory</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="179"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="81"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="234"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="105"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Wound Issue - Non-infection</sub_title>
                <description>including Hematoma, Hematoma Evacuation and CSF Leakage</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="81"/>
                <counts group_id="E3" events="2" subjects_affected="2" subjects_at_risk="234"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="105"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Trauma</sub_title>
                <description>includes falls, motor vehicle accidents, assault, injury, etc. This category includes both cervical and non-cervical AEs of Trauma.</description>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="179"/>
                <counts group_id="E2" events="8" subjects_affected="5" subjects_at_risk="81"/>
                <counts group_id="E3" events="10" subjects_affected="7" subjects_at_risk="234"/>
                <counts group_id="E4" subjects_affected="2" subjects_at_risk="105"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Anatomy/Technical Difficulty</sub_title>
                <description>Anatomy/Technical Difficulty includes Cervical – Study Surgery, Cervical – Non Study Surgery and Non Cervical</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="179"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="81"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="234"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="105"/>
              </event>
              <event>
                <sub_title>Malpositioned implant</sub_title>
                <description>includes misplaced screw, subsidence, a sub optimal or undesired position, regardless of causality. This is not mutually exclusive to surgeon error or sub-optimal placement of the original implant configuration.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="179"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="81"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="234"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="105"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_vocab>MedDRA (10.0)</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="170" subjects_at_risk="179"/>
                <counts group_id="E2" subjects_affected="75" subjects_at_risk="81"/>
                <counts group_id="E3" subjects_affected="209" subjects_at_risk="234"/>
                <counts group_id="E4" subjects_affected="100" subjects_at_risk="105"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiovascular</sub_title>
                <counts group_id="E1" events="26" subjects_affected="20" subjects_at_risk="179"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="81"/>
                <counts group_id="E3" events="29" subjects_affected="21" subjects_at_risk="234"/>
                <counts group_id="E4" events="12" subjects_affected="10" subjects_at_risk="105"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gastrointestinal</sub_title>
                <counts group_id="E1" events="60" subjects_affected="39" subjects_at_risk="179"/>
                <counts group_id="E2" events="37" subjects_affected="15" subjects_at_risk="81"/>
                <counts group_id="E3" events="97" subjects_affected="47" subjects_at_risk="234"/>
                <counts group_id="E4" events="52" subjects_affected="32" subjects_at_risk="105"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="81"/>
                <counts group_id="E3" events="1" subjects_affected="1" subjects_at_risk="234"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="105"/>
              </event>
              <event>
                <sub_title>Other</sub_title>
                <counts group_id="E1" events="114" subjects_affected="77" subjects_at_risk="179"/>
                <counts group_id="E2" events="66" subjects_affected="33" subjects_at_risk="81"/>
                <counts group_id="E3" events="189" subjects_affected="99" subjects_at_risk="234"/>
                <counts group_id="E4" events="104" subjects_affected="58" subjects_at_risk="105"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infection</sub_title>
                <counts group_id="E1" events="51" subjects_affected="33" subjects_at_risk="179"/>
                <counts group_id="E2" events="28" subjects_affected="20" subjects_at_risk="81"/>
                <counts group_id="E3" events="98" subjects_affected="56" subjects_at_risk="234"/>
                <counts group_id="E4" events="50" subjects_affected="30" subjects_at_risk="105"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Heterotopic Ossification</sub_title>
                <counts group_id="E1" events="10" subjects_affected="9" subjects_at_risk="179"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="81"/>
                <counts group_id="E3" events="6" subjects_affected="6" subjects_at_risk="234"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="105"/>
              </event>
              <event>
                <sub_title>Neck and/or Arm Pain</sub_title>
                <counts group_id="E1" events="212" subjects_affected="101" subjects_at_risk="179"/>
                <counts group_id="E2" events="98" subjects_affected="47" subjects_at_risk="81"/>
                <counts group_id="E3" events="167" subjects_affected="102" subjects_at_risk="234"/>
                <counts group_id="E4" events="111" subjects_affected="63" subjects_at_risk="105"/>
              </event>
              <event>
                <sub_title>Non-Union</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="179"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="81"/>
                <counts group_id="E3" events="3" subjects_affected="1" subjects_at_risk="234"/>
                <counts group_id="E4" events="18" subjects_affected="13" subjects_at_risk="105"/>
              </event>
              <event>
                <sub_title>Other Pain</sub_title>
                <counts group_id="E1" events="226" subjects_affected="102" subjects_at_risk="179"/>
                <counts group_id="E2" events="144" subjects_affected="47" subjects_at_risk="81"/>
                <counts group_id="E3" events="267" subjects_affected="131" subjects_at_risk="234"/>
                <counts group_id="E4" events="132" subjects_affected="64" subjects_at_risk="105"/>
              </event>
              <event>
                <sub_title>Spinal Disorder</sub_title>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="179"/>
                <counts group_id="E2" events="12" subjects_affected="10" subjects_at_risk="81"/>
                <counts group_id="E3" events="18" subjects_affected="13" subjects_at_risk="234"/>
                <counts group_id="E4" events="20" subjects_affected="13" subjects_at_risk="105"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Cancer</sub_title>
                <counts group_id="E1" events="5" subjects_affected="4" subjects_at_risk="179"/>
                <counts group_id="E2" events="2" subjects_affected="1" subjects_at_risk="81"/>
                <counts group_id="E3" events="3" subjects_affected="3" subjects_at_risk="234"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="105"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Neurological</sub_title>
                <counts group_id="E1" events="401" subjects_affected="121" subjects_at_risk="179"/>
                <counts group_id="E2" events="215" subjects_affected="52" subjects_at_risk="81"/>
                <counts group_id="E3" events="426" subjects_affected="124" subjects_at_risk="234"/>
                <counts group_id="E4" events="278" subjects_affected="78" subjects_at_risk="105"/>
              </event>
              <event>
                <sub_title>Upper Extremity Nerve Entrapment</sub_title>
                <counts group_id="E1" events="9" subjects_affected="8" subjects_at_risk="179"/>
                <counts group_id="E2" events="5" subjects_affected="4" subjects_at_risk="81"/>
                <counts group_id="E3" events="16" subjects_affected="13" subjects_at_risk="234"/>
                <counts group_id="E4" events="7" subjects_affected="6" subjects_at_risk="105"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Urogenital</sub_title>
                <counts group_id="E1" events="11" subjects_affected="9" subjects_at_risk="179"/>
                <counts group_id="E2" events="12" subjects_affected="9" subjects_at_risk="81"/>
                <counts group_id="E3" events="23" subjects_affected="15" subjects_at_risk="234"/>
                <counts group_id="E4" events="14" subjects_affected="10" subjects_at_risk="105"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Dysphagia/Dysphonia</sub_title>
                <counts group_id="E1" events="26" subjects_affected="20" subjects_at_risk="179"/>
                <counts group_id="E2" events="20" subjects_affected="17" subjects_at_risk="81"/>
                <counts group_id="E3" events="43" subjects_affected="39" subjects_at_risk="234"/>
                <counts group_id="E4" events="27" subjects_affected="24" subjects_at_risk="105"/>
              </event>
              <event>
                <sub_title>Respiratory</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="179"/>
                <counts group_id="E2" events="8" subjects_affected="6" subjects_at_risk="81"/>
                <counts group_id="E3" events="29" subjects_affected="19" subjects_at_risk="234"/>
                <counts group_id="E4" events="12" subjects_affected="11" subjects_at_risk="105"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Wound Issue -- Non-Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="179"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="81"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="234"/>
                <counts group_id="E4" events="3" subjects_affected="3" subjects_at_risk="105"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Social circumstances</title>
            <event_list>
              <event>
                <sub_title>Trauma</sub_title>
                <counts group_id="E1" events="70" subjects_affected="47" subjects_at_risk="179"/>
                <counts group_id="E2" events="38" subjects_affected="20" subjects_at_risk="81"/>
                <counts group_id="E3" events="89" subjects_affected="52" subjects_at_risk="234"/>
                <counts group_id="E4" events="36" subjects_affected="20" subjects_at_risk="105"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Anatomy/Techical Difficulty</sub_title>
                <counts group_id="E1" events="12" subjects_affected="11" subjects_at_risk="179"/>
                <counts group_id="E2" events="4" subjects_affected="2" subjects_at_risk="81"/>
                <counts group_id="E3" events="9" subjects_affected="9" subjects_at_risk="234"/>
                <counts group_id="E4" events="5" subjects_affected="5" subjects_at_risk="105"/>
              </event>
              <event>
                <sub_title>Malpositioned Implant</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="179"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="81"/>
                <counts group_id="E3" events="4" subjects_affected="4" subjects_at_risk="234"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="105"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Vascular Intraoperative</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="179"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="81"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="234"/>
                <counts group_id="E4" events="1" subjects_affected="1" subjects_at_risk="105"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The clinical site must submit to the Company, for review, any manuscripts, papers, summaries, abstracts, outlines or other media for publication at least 60 days before disclosure for the Company to review. The company has 30 days to review the proposed publication for any patentable subject matter or designated confidential information or confidential health information and by written notice to the site/PI identify such text so that the Company has time to file a patent application.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Noah Bartsch, VP, Clinical,Regulatory,Quality</name_or_title>
      <organization>LDR Spine</organization>
      <phone>512-344-3319</phone>
      <email>noah.bartsch@ldrspine.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

